Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases.

J Transl Med · 2017 · PMC5412048 · PMID 28460632

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

[ 48 ] observed, in a cohort of 278 patients from the GeparTrio trial, a highly significant correlation and a high overall agreement between IHC, supplemented by SISH for equivocal cases, and qRT-PCR in determining HER2 status.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.